Marengo Nominates First Drug Candidate Under Strategic TriSTAR Collaboration with Ipsen and Welcomes Industry-Leading T-Cell Engager Expert, Saso Cemerski, Ph.D., to Accelerate Pipeline Expansion

PartnershipTriSTAR program drug candidatePositive

AI Analysis

Summary

Marengo nominates its first drug candidate under a strategic TriSTAR collaboration with Ipsen and advances it into IND-enabling development. The company also appoints industry expert Saso Cemerski as Senior Vice President, Head of Immunology to accelerate pipeline expansion.

Outcome Details

First TriSTAR partnered program advances into IND-enabling development

Importance:6/10

Sentiment:

0.70

PartnershipCollaborationIND-enablingT-cell engagerPipeline expansionLeadership appointment

Related Companies

$IPN.PA

Read the original article

Published by PR Newswire Biotech on August 4, 2026 11:00 AM

Read Original